版本:
中国

BRIEF-Biogen acquires Remedy Pharmaceuticals' late-stage drug cirara

May 18 Biogen Inc

* Biogen acquires Remedy Pharmaceuticals' late-stage drug cirara

* Biogen Inc says Biogen made an upfront payment of $120 million to remedy and may also pay additional milestone payments and royalties

* Says Biogen made an upfront payment of $120 million to remedy and may also pay additional milestone payments and royalties Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐